welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Label-Free Global Serum Proteomic Profiling Reveals Novel Celecoxib-Modulated Proteins in Familial Adenomatous Polyposis Patients
source: Cancer genomics & proteomics
year: 2009
authors: Fatima N, Chelius D, Luke B T, Yi M, Zhang T, Stauffer S, Stephens R, Lynch P, Miller K, Guszczynski T, Boring D, Greenwald P, Ali I U
summary/abstract:Celecoxib, a selective inhibitor of cyclooxygenase-2 (Cox-2), was efficacious in clinical prevention trials of patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer. To identify as yet poorly defined molecular determinants of celecoxib efficacy, a multidimensional serum fractionation approach was used coupled with nanospray tandem mass spectrometry to perform label-free global proteomic profiling of serum samples from the FAP/celecoxib prevention trial. Subsequently, the application of an algorithm for large-scale biomarker discovery on comparative serum proteomic profiles of pre- and post-celecoxib treatment samples identified 83 potentially celecoxib-responsive proteins from various cellular compartments, biological processes and molecular functions. Celecoxib modulation of some of these proteins was confirmed in serum samples of FAP patients and colorectal cancer cell lines by Western blotting. Thus, using a shotgun procedure to rapidly identify important celecoxib-modulated proteins, this pilot study has uncovered novel systemic changes some of which are highly relevant for carcinogenesis and vascular biology. Validation of selected markers, especially those involved in key signaling networks and those considered molecular indicators of cardiovascular pathology, in larger celecoxib clinical trials is expected to provide insights into the molecular mechanisms of celecoxib and the efficacy/toxicity issues related to its use as a chemopreventive agent.
organization: University of Karachiread more full text source
expertly curated content related to this topic
-
Medication Education: F.A.P. and Medicationhttps://www.youtube.com/watch?v=UOQ94Rse...
-
Meta-Analysis of Observational Studies of Ileorectal Versus Ileal Pouch-Anal Anastomosis for Familial Adenomatous Po...BACKGROUND : Surgery for familial adenom...
-
Rectal and Pouch Recurrences After Surgical Treatment for Familial Adenomatous PolyposisBACKGROUND : Familial adenomatous polypo...
-
Rectal Epithelial Apoptosis in Familial Adenomatous Polyposis Patients Treated with SulindacBACKGROUND : Sulindac regresses colorect...
-
Guidelines for the Clinical Management of Familial Adenomatous Polyposis (FAP)Background: Familial adenomatous polypos...
-
Victoria’s OTHER Secret: Designer Creates World’s first Lingerie Colostomy Bags as They often Put Partners OffA young designer has taken fashion into ...
-
Genetics, Inheritance and Strategies for Prevention in Populations at High Risk of Colorectal Cancer (CRC)Hereditary forms of colorectal cancer ac...